SEL-302
- Generic Name
- SEL-302
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
SEL-302 is a recombinant adeno-associated virus vector-based gene therapy expressing the methylmalonyl-CoA mutase (MMUT) transgene.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05778877
- Locations
- 🇺🇸
National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath